{
  "id": 2960750,
  "title": "Hanmi Pharm signs 3.2 tln-won licensing deal with Roche's Genentech for obesity drug candidate",
  "url": "https://urgent.news/2026/08/24/hanmi-pharm-signs-3-2-tln-won-licensing-deal-with-roches-genentech",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-24T06:00:25.000Z",
  "source": {
    "name": "Yonhap News",
    "slug": "yonhap-news",
    "url": "https://en.yna.co.kr/view/AEN20260824006600320"
  },
  "original_language": "en",
  "account": null,
  "summary": "SEOUL, Aug. 24 (Yonhap) -- Hanmi Pharm. Co., a South Korean pharmaceutical compa...",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 5,
    "also_reported_by": [
      {
        "outlet": "Investing.com",
        "title": "Hanmi Pharm shares jump 30% on Genentech obesity drug deal",
        "url": "https://urgent.news/2026/08/24/hanmi-pharm-shares-jump-30-on-genentech-obesity-drug-deal",
        "published": "2026-08-24T05:16:46.000Z"
      },
      {
        "outlet": "The Korea Times",
        "title": "Hanmi Pharm signs $2.3 bil. licensing deal with Roche's Genentech for obesity drug candidate",
        "url": "https://urgent.news/2026/08/24/hanmi-pharm-signs-2-3-bil-licensing-deal-with-roches-genentech-for",
        "published": "2026-08-24T06:27:02.000Z"
      },
      {
        "outlet": "BusinessKorea",
        "title": "Hanmi Licenses Obesity Drug To Genentech",
        "url": "https://urgent.news/2026/08/24/hanmi-licenses-obesity-drug-to-genentech",
        "published": "2026-08-24T07:08:16.000Z"
      },
      {
        "outlet": "Endpoints News",
        "title": "Roche bets up to $2.3B on Hanmi’s early-stage muscle-building obesity asset",
        "url": "https://urgent.news/2026/08/24/roche-bets-up-to-2-3b-on-hanmis-early-stage-muscle-building-obesity",
        "published": "2026-08-24T10:56:51.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}